Katherine Kalin's Insider Trades & SAST Disclosures
Katherine Kalin's most recent trade in SELLAS Life Sciences Group Inc was a trade of 18,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Katherine Kalin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group... | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 12,500 | 21,000 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Bach Katherine Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Katherine Kalin Bach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 6,000 | 8,500 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 9,500 | 9,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 2,500 | 2,500 (0%) | 0% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Katherine Bach Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Athersys Inc | Katherine Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 50,000 | 50,000 | - | - | NonQualified Stock Option (right to purchase) | |
| Athersys Inc | Katherine Kalin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2020 | 100,000 | 100,000 | - | - | NonQualified Stock Option (right to purchase) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges